QuickView for costamere (biogroup)

1. L1000 CMAP - Adipocyte ASC cells treated with small molecule perturbagens
2. L1000 CMAP - Embryonic stem HUES3 cells treated with small molecule perturbagens
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
4. L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)

1. Novel interactions of ankyrins-G at the costameres: the muscle-specific Obscurin/Titin-Binding-relat…
2. Costameric proteins: from benchside to future translational cardiovascular research.
3. Obscurin is required for ankyrinB-dependent dystrophin localization and sarcolemma integrity.
4. Cardiac-specific deletion of the microtubule-binding protein CENP-F causes dilated cardiomyopathy.
5. Quantitative changes in focal adhesion kinase and its inhibitor, FRNK, drive load-dependent expressi…

There were no clinical trials for costamere